According to Zhitong Finance App, Puluo Pharmaceutical (000739.SZ) released its report for the third quarter of 2026. The company achieved operating income of 6.835 billion yuan in the first three quarters, down 11.97% year on year; net profit attributable to shareholders of listed companies was 614 million yuan, down 12.37% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 568 million yuan, down 12.22% year on year; basic earnings per share were 0.5309 yuan.

According to Zhitong Finance App, Puluo Pharmaceutical (000739.SZ) released its report for the third quarter of 2026. The company achieved operating income of 6.835 billion yuan in the first three quarters, down 11.97% year on year; net profit attributable to shareholders of listed companies was 614 million yuan, down 12.37% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 568 million yuan, down 12.22% year on year; basic earnings per share were 0.5309 yuan.